Neograft Technologies Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Neograft Technologies General Information

Description

Developer of a cardiac device designed to improve vein performance in coronary artery bypass. The company's cardiac device creates a support layer around the vein using a novel process called electrospinning, allowing patients with nutrients and new cells to migrate into and through the support layer without deforming its natural shape.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 470 Constitution Drive
  • Taunton, MA 02780
  • United States
Primary Industry
Surgical Devices
Corporate Office
  • 470 Constitution Drive
  • Taunton, MA 02780
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neograft Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 01-Apr-2019 Completed Out of Business
6. Accelerator/Incubator Completed Generating Revenue
5. Later Stage VC (Series C) 26-Jan-2017 Completed Generating Revenue
4. Later Stage VC (Series C) 14-Jul-2014 Completed Startup
3. Early Stage VC (Series B) 30-Aug-2013 Completed Startup
2. Early Stage VC (Series B) 21-Dec-2010 $3M $9.3M Completed Startup
1. Early Stage VC (Series A) 19-Jan-2010 $6.3M $6.3M Completed Startup
To view Neograft Technologies’s complete valuation and funding history, request access »

Neograft Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 14,535,739 $0.001000 $0.54 $0.54 1x $0.54 26.96%
To view Neograft Technologies’s complete cap table history, request access »

Neograft Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cardiac device designed to improve vein performance in coronary artery bypass. The company's cardiac devi
Surgical Devices
Taunton, MA

Netanya, Israel

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neograft Technologies Competitors (22)

One of Neograft Technologies’s 22 competitors is Transseptal, a Corporation company based in Netanya, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Transseptal Corporation Netanya, Israel
Revolve Surgical Venture Capital-Backed Toronto, Canada
Spine Wave Venture Capital-Backed Shelton, CT
Asensus Surgical Formerly VC-backed Durham, NC
Elliquence Corporate Backed or Acquired Baldwin, NY
You’re viewing 5 of 22 competitors. Get the full list »

Neograft Technologies Patents

Neograft Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019237014-A1 Multiple layer vascular graft Inactive 08-Jun-2018
WO-2017214537-A1 System for producing a graft device with a three-dimensional covering Inactive 10-Jun-2016
US-20180368968-A1 System for creating a graft device Inactive 21-Dec-2015
WO-2017112710-A1 System for creating a graft device Inactive 21-Dec-2015
EP-3089704-A1 Self-diagnostic graft production systems and related methods Inactive 31-Dec-2013 A61F2/06
To view Neograft Technologies’s complete patent history, request access »

Neograft Technologies FAQs

  • When was Neograft Technologies founded?

    Neograft Technologies was founded in 2009.

  • Where is Neograft Technologies headquartered?

    Neograft Technologies is headquartered in Taunton, MA.

  • What industry is Neograft Technologies in?

    Neograft Technologies’s primary industry is Surgical Devices.

  • Is Neograft Technologies a private or public company?

    Neograft Technologies is a Private company.

  • What is Neograft Technologies’s current revenue?

    The current revenue for Neograft Technologies is .

  • How much funding has Neograft Technologies raised over time?

    Neograft Technologies has raised $37.3M.

  • Who are Neograft Technologies’s competitors?

    Transseptal, Revolve Surgical, Spine Wave, Asensus Surgical, and Elliquence are some of the 22 competitors of Neograft Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process